NSE: LTIM | BSE: 540005

Turnaround Potential

Download real time

5699.00 25.00 (0.44%)

49.89% Gain from 52W Low

222.4K NSE+BSE Volume

NSE 30 Oct, 2025 3:31 PM (IST)

168,969.2

Market Cap

High in industry

1.2

Beta 1Year

Very High Volatility

LTIMindtree Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LTIM, BSE:540005 LTIMindtree Ltd.

LTIMindtree Ltd.

17 Jul 2025

5699.00

0.44%

In-line Quarter, On steady growth path

Buy: LTIMindtree Ltd.

Sharekhan

Reported revenues stood at $1,153 million, up 0.8% q-o-q/ 4.4% y-o-y in CC terms, slightly missing our estimates of 1% q-o-q growth in CC terms. Sequential growth was led by Consumer business and Healthcare, Lifesciences & Public Services verticals.

Number of FII/FPI investors decreased from 542 to 534 in Sep 2025 qtr

LTIMindtree Ltd.

12 Jun 2025

5699.00

0.44%

Strong order inflow to aid growth

Buy: LTIMindtree Ltd.

Target

Sharekhan

We interacted with LTIMindtree’s management to understand the company’s business strategy and growth prospects. For Q1FY26, LTIMindtree expects strong order inflow to continue, bolstered by a landmark $450 million, seven-year deal, following robust order inflows of $1.68 billion in Q3FY25 and $1.6 billion in Q4FY25.

LTIMindtree Ltd. has an average target of 5934.12 from 9 brokers.

LTIMindtree Ltd.

06 May 2025

5699.00

0.44%

LTIMINDTREE LIMITED

Hold: LTIMindtree Ltd.

Recommendation Target

Geojit BNP Paribas

LTIMindtree Ltd. has gained 23.94% in the last 6 Months

LTIMindtree Ltd.

24 Apr 2025

5699.00

0.44%

LTIMindtree: Q4FY25 Result Review

Buy: LTIMindtree Ltd.

Recommendation Target

IDBI Capital

Number of FII/FPI investors decreased from 542 to 534 in Sep 2025 qtr

LTIMindtree Ltd.

24 Apr 2025

5699.00

0.44%

Healthcare slip impacts growth sharply

Hold: LTIMindtree Ltd.

Target

ICICI Securities Limited

LTIM reported muted performance with revenue growth down 0.6%/0.7% CC/USD QoQ, underperforming I-Sec estimates. Factors leading to slower growth were, Delayed ramp-up and deferral of deals, Ramp-down in healthcare vertical and Top-5 clients’ revenue declining from AI-led gain sharing.

Number of FII/FPI investors decreased from 542 to 534 in Sep 2025 qtr

LTIMindtree Ltd.

24 Apr 2025

5699.00

0.44%

LTIMindtree (LTIM IN) Q4FY25 Result Update Hinting positive...

Accumulate: LTIMindtree Ltd.

Recommendation Target

Prabhudas Lilladhar

The revenue growth (-0.6% QoQ CC) was below our estimates (+0.3% QoQ CC), while margins were fairly in line, attributed to project closures and unanticipated delays in deal ramp ups. The new management is doubling down on three key initiatives to maximize revenues and improve profitability. The management expects new initiatives to start reaping benefits from Q1FY26, it expects Q1 to be a growth quarter with sequential improvement in margins. Despite having 34% dependency on tariff sensitive verticals (Manufacturing...

LTIMindtree Ltd. is trading above all available SMAs

LTIMindtree Ltd.

23 Apr 2025

5699.00

0.44%

Muted Quarter, Gradual recovery eyed

Buy: LTIMindtree Ltd.

Target

Sharekhan

Reported revenues stood at $1,131 million, down 0.6% q-o-q/ 6.3% y-o-y in CC missing our estimates of 0.2% q-o-q growth in CC. Rupee revenues stood at Rs 9,772 crore, up 1.1% q-o-q/9.9% y-o-y.

LTIMindtree Ltd. has gained 23.94% in the last 6 Months

LTIMindtree Ltd.

23 Apr 2025

5699.00

0.44%

A weak quarter, but reset in progress

Buy: LTIMindtree Ltd.

Target

Motilal Oswal

LTIMindtree (LTIM) reported 4QFY25 revenue of USD1.1b, down 0.6% QoQ CC and below our estimate of flat QoQ CC. FY25 revenue stood at USD4.5b, up 5.0% YoY CC. 4Q EBIT margin at 13.8% was in line with our estimate of 13.8%.